1110 related articles for article (PubMed ID: 16983741)
21. Preoperative chemoradiation for rectal cancer causes prolonged pudendal nerve terminal motor latency.
Lim JF; Tjandra JJ; Hiscock R; Chao MW; Gibbs P
Dis Colon Rectum; 2006 Jan; 49(1):12-9. PubMed ID: 16292664
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
[TBL] [Abstract][Full Text] [Related]
23. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
24. Preoperative chemoradiation and coloanal J pouch reconstruction for low rectal cancer.
Chaudhry V; Nittala M; Prasad ML
Am Surg; 2000 Apr; 66(4):387-93. PubMed ID: 10776877
[TBL] [Abstract][Full Text] [Related]
25. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
Peeters KC; van de Velde CJ; Leer JW; Martijn H; Junggeburt JM; Kranenbarg EK; Steup WH; Wiggers T; Rutten HJ; Marijnen CA
J Clin Oncol; 2005 Sep; 23(25):6199-206. PubMed ID: 16135487
[TBL] [Abstract][Full Text] [Related]
26. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
[TBL] [Abstract][Full Text] [Related]
27. Management of rectal cancer: short- vs. long-course preoperative radiation.
Mohiuddin M; Marks J; Marks G
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):636-43. PubMed ID: 19014778
[TBL] [Abstract][Full Text] [Related]
28. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience.
Sun Myint A; Lee CD; Snee AJ; Perkins K; Jelley FE; Wong H
Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):711-9. PubMed ID: 17884396
[TBL] [Abstract][Full Text] [Related]
29. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.
Gérard JP; Conroy T; Bonnetain F; Bouché O; Chapet O; Closon-Dejardin MT; Untereiner M; Leduc B; Francois E; Maurel J; Seitz JF; Buecher B; Mackiewicz R; Ducreux M; Bedenne L
J Clin Oncol; 2006 Oct; 24(28):4620-5. PubMed ID: 17008704
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant radiochemotherapy for rectal cancer.
Vini L
Dig Dis; 2007; 25(1):56-66. PubMed ID: 17384509
[TBL] [Abstract][Full Text] [Related]
31. Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant chemoradiotherapy.
Valenti V; Hernandez-Lizoain JL; Baixauli J; Pastor C; Aristu J; Diaz-Gonzalez J; Beunza JJ; Alvarez-Cienfuegos JA
Ann Surg Oncol; 2007 May; 14(5):1744-51. PubMed ID: 17334851
[TBL] [Abstract][Full Text] [Related]
32. Counterpoint: long-course chemoradiation is preferable in the neoadjuvant treatment of rectal cancer.
Minsky BD
Semin Radiat Oncol; 2011 Jul; 21(3):228-33. PubMed ID: 21645868
[TBL] [Abstract][Full Text] [Related]
33. Distal bowel surgical margin shorter than 1 cm after preoperative radiation for rectal cancer: is it safe?
Rutkowski A; Bujko K; Nowacki MP; Chmielik E; Nasierowska-Guttmejer A; Wojnar A;
Ann Surg Oncol; 2008 Nov; 15(11):3124-31. PubMed ID: 18766404
[TBL] [Abstract][Full Text] [Related]
34. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
35. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
[TBL] [Abstract][Full Text] [Related]
36. Late adverse effects of short-course preoperative radiotherapy in rectal cancer.
Pollack J; Holm T; Cedermark B; Altman D; Holmström B; Glimelius B; Mellgren A
Br J Surg; 2006 Dec; 93(12):1519-25. PubMed ID: 17054311
[TBL] [Abstract][Full Text] [Related]
37. A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer.
Kundel Y; Brenner B; Symon Z; Oberman B; Sadezki S; Koller M; Catane R; Pfeffer R
Anticancer Res; 2007; 27(4C):2877-80. PubMed ID: 17695464
[TBL] [Abstract][Full Text] [Related]
38. Postoperative chemoradiotherapy in rectal cancer. Late results of a pilot study.
Tersigni R; Alessandroni L; Arcangeli G; Baiano G; Marini P; Micheli A; Sorgi G
Hepatogastroenterology; 2004; 51(60):1679-85. PubMed ID: 15532804
[TBL] [Abstract][Full Text] [Related]
39. Short course continuous, hyperfractionated, accelerated radiation therapy (CHART) as preoperative treatment for rectal cancer.
Brooks S; Glynne-Jones R; Novell R; Harrison M; Brown K; Makris A
Acta Oncol; 2006; 45(8):1079-85. PubMed ID: 17118843
[TBL] [Abstract][Full Text] [Related]
40. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival.
Wiltshire KL; Ward IG; Swallow C; Oza AM; Cummings B; Pond GR; Catton P; Kim J; Ringash J; Wong CS; Wong R; Siu LL; Moore M; Brierley J
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):709-16. PubMed ID: 16242252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
